» Authors » Bruce Ashford

Bruce Ashford

Explore the profile of Bruce Ashford including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 327
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Douglas C, Hewitt L, Yabe T, Mitchell J, Ashford B
World J Oncol . 2023 May; 14(2):150-157. PMID: 37188036
Background: Understanding the impact of surgery on patients will enable clinicians to provide evidence-based perioperative management. This study aimed to investigate the quality of life (QoL) impacts following head and...
12.
Gupta R, Strbenac D, Satgunaseelan L, Cheung V, Narayanappa H, Ashford B, et al.
Mod Pathol . 2023 Apr; 36(8):100190. PMID: 37080394
Squamous cell carcinoma is the most common head and neck malignancy arising from the oral mucosa and the skin. The histologic and immunohistochemical features of oral squamous cell carcinoma (OSCC)...
13.
Milosavljevic M, Hewitt L, Fish J, Davis K, McManus L, Ashford B
Intern Med J . 2023 Mar; 53(3):416-421. PMID: 36972986
Researchers have reported limitations with research governance processes across Australia. This study aimed to streamline research governance processes across a local health district. Four basic principles were applied to remove...
14.
Tan B, Seth I, Fischer O, Hewitt L, Melville G, Bulloch G, et al.
Cancers (Basel) . 2022 Dec; 14(23). PMID: 36497312
The incidence of head and neck cutaneous squamous cell carcinoma (HNcSCC) is unevenly distributed between men and women. At present, the mechanism behind this disparity remains elusive. This study conducted...
15.
Hewitt L, Ashford B
ANZ J Surg . 2022 Nov; 93(1-2):21-23. PMID: 36420700
No abstract available.
16.
Hurrell M, Hubert Low T, Ebrahimi A, Veness M, Ashford B, Porceddu S, et al.
Cancers (Basel) . 2022 Oct; 14(20). PMID: 36291884
Cutaneous squamous cell carcinoma of the head and neck (HNcSCC) is one of the commonest malignancies. When patients present with regional metastatic disease, treatment escalation results in considerable morbidity and...
17.
Ferguson A, Sharman A, Allen R, Ye T, Lee J, Low T, et al.
Clin Cancer Res . 2022 Aug; 28(21):4677-4688. PMID: 36044477
Purpose: The tumor immune microenvironment impacts the biological behavior of the tumor, but its effect on clinical outcomes in head and neck cutaneous squamous cell carcinomas (HNcSCC) is largely unknown....
18.
Thind A, Ashford B, Strbenac D, Mitchell J, Lee J, Mueller S, et al.
Front Oncol . 2022 Aug; 12:919118. PMID: 35982973
Metastatic cutaneous squamous cell carcinoma (CSCC) is a highly morbid disease requiring radical surgery and adjuvant therapy, which is associated with a poor prognosis. Yet, compared to other advanced malignancies,...
19.
Genenger B, Perry J, Ashford B, Ranson M
Discov Oncol . 2022 Jun; 13(1):42. PMID: 35666359
Cutaneous squamous cell carcinoma (cSCC) is a disease with globally rising incidence and poor prognosis for patients with advanced or metastatic disease. Epithelial-mesenchymal transition (EMT) is a driver of metastasis...
20.
Milosavljevic M, Hewitt L, Fish J, Cuenca J, Ashford B
Intern Med J . 2022 May; 52(5):853-858. PMID: 35538005
Most clinicians find research ethics and governance difficult and time consuming. This study aimed to develop a better local review process for low-risk research. We used real-time processing, leveraged local...